PropertyValue
?:definition
  • Molecular assay reagents intended to identify mutations in the majority of genes known to be associated with neuromuscular disorders, a collection of diseases characterized by impairment of skeletal muscle function. Genetic variants at multiple loci have been associated with neuromuscular disorders. These reagents are intended to detect mutations in the majority of neuromuscular disorder-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4286773_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4286773_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all